Avadel Pharma (AVDL) Misses Q2 EPS by 65c

Avadel Pharma (NASDAQ: AVDL) reported Q2 EPS of ($1.07), $0.65 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Bernstein SocGen on Oracle (ORCL): 'Next catalyst is FAM'
• UBS Reiterates Buy Rating on Darden Restaurants (DRI) Ahead of Q1 Earnings